跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61 条关于
“Synecta CDNPs”
全部
61
临床试验
42
药物
6
机构
5
资讯
8
去年
Kytopen and BlueWhale Bio Partner to Accelerate Non-Viral Cell Therapy Manufacturing
去年
BlueWhale Bio Doses First Patient with Novel Cell-Derived Nanoparticle Technology for CAR-T Manufacturing
去年
SynAct Pharma Launches Phase II Trial of Resomelagon for Dengue Treatment in Brazil
去年
SynAct Pharma Secures Extended US Patent Protection for Resomelagon Combination Therapy Until 2042
去年
SynAct Pharma's Resomelagon Receives EU Trial Approval for Phase 2b Rheumatoid Arthritis Study
去年
Redeye: SynAct Pharma Q1 2025 - New Phase II Study in Dengue Fever - TradingView
7个月前
SynAct Pharma Completes Enrollment in Phase 2b Trial of Resomelagon for Newly Diagnosed Rheumatoid Arthritis
去年
SynAct Pharma Secures SEK 30 Million Credit Facility to Advance Rheumatoid Arthritis Drug Development Through Mid-2026